Over half of the WHO guidelines published from 2014 to 2019 explicitly considered health equity issues: a cross-sectional survey

dc.contributor.authorDewidar, Omar
dc.contributor.authorTsang, Phillip
dc.contributor.authorLeón, Montserrat
dc.contributor.authorMathew, Christine M.
dc.contributor.authorAntequera, Alba
dc.contributor.authorBaldeh, Tejan
dc.contributor.authorAkl, Elie A.
dc.contributor.authorAlonso-Coello, Pablo
dc.contributor.authorPetkovic, Jennifer
dc.contributor.authorPiggott, Thomas
dc.contributor.authorPottie, Kevin C.
dc.contributor.authorSchunëmann, Holger J.
dc.contributor.authorTugwell, Peter S.L.
dc.contributor.authorWelch, Vivian A.
dc.contributor.departmentInternal Medicine
dc.contributor.facultyFaculty of Medicine (FM)
dc.contributor.institutionAmerican University of Beirut
dc.date.accessioned2025-01-24T11:57:38Z
dc.date.available2025-01-24T11:57:38Z
dc.date.issued2020
dc.description.abstractObjective: To evaluate how and to what extent health equity considerations are assessed in World Health Organization (WHO) guidelines. Study Design and Setting: We evaluated WHO guidelines published between January 2014 and May 2019. Health equity considerations were assessed in relation to differences in baseline risk, importance of outcomes for socially disadvantaged populations, inclusion of health inequity as an outcome, equity-related subgroup analysis, and indirectness in each recommendation. Results: We identified 111 WHO guidelines, and 54% (60 of 111) of these used the Evidence to Decision (EtD) framework. For the 60 guidelines using an EtD framework, the likely impact on health equity was supported by research evidence in 28% of the recommendations (94 of 332). Research evidence was mostly provided as differences in baseline risk (23%, 78/332). Research evidence less frequently addressed the importance of outcomes for socially disadvantaged populations (11%, 36/332), considered indirectness of the evidence for socially disadvantaged populations (2%, 5/332), considered health inequities as an outcome (2%, 5/332) and considered differences in the magnitude of effect in relative terms between disadvantaged and more advantaged populations (1%, 3/332). Conclusion: The provision of research evidence to support equity judgements in WHO guidelines is still suboptimal, suggesting the need for better guidance and more training. © 2020 Elsevier Inc.
dc.identifier.doihttps://doi.org/10.1016/j.jclinepi.2020.07.012
dc.identifier.eid2-s2.0-85089729628
dc.identifier.pmid32717312
dc.identifier.urihttp://hdl.handle.net/10938/31302
dc.language.isoen
dc.publisherElsevier USA
dc.relation.ispartofJournal of Clinical Epidemiology
dc.sourceScopus
dc.subjectEvidence to decision
dc.subjectGrade
dc.subjectGuideline development
dc.subjectGuidelines
dc.subjectHealth equity
dc.subjectWho
dc.subjectCross-sectional studies
dc.subjectGuidelines as topic
dc.subjectHealthcare disparities
dc.subjectHumans
dc.subjectVulnerable populations
dc.subjectWorld health organization
dc.subjectArticle
dc.subjectDecision making
dc.subjectHuman
dc.subjectOutcome assessment
dc.subjectPractice guideline
dc.subjectCross-sectional study
dc.subjectHealth care disparity
dc.subjectVulnerable population
dc.titleOver half of the WHO guidelines published from 2014 to 2019 explicitly considered health equity issues: a cross-sectional survey
dc.typeArticle

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
2020-3053.pdf
Size:
983.79 KB
Format:
Adobe Portable Document Format